This study demonstrates the value of non-invasive multiparametric quantitative MRI for longitudinal assessment of tau pathology in the rTg4510 model and monitoring distinct properties that reflect the biological responses to therapy in AD. The gene discussed is MAPT; the disease is Alzheimer disease.